Peng Lab

General Aim

To decipher the molecular mechanisms driving tumor development, progression, and resistance to standard clinical cancer therapies in lung cancer and malignant pleural mesothelioma (MPM), with the goal of uncovering therapeutically exploitable vulnerabilities - the ‘Achilles’ heel’ - of therapy-naïve and refractory cancer cells to develop innovative precision medicine strategies for the treatment of thoracic tumors.